During the past decade, Michigan Health Professionals conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Health Professionals" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Michigan Health Professionals" are "Locally Advanced or Metastatic Castration-resistant Prostate Cancer" (1 trials), "Locally Advanced or Metastatic ER+ HER2- Breast Cancer" (1 trials), "Locally Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Michigan Health Professionals" in a lesser frequency.

Most popular intervention types in "Michigan Health Professionals" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Binimetinib" (1 trials), "Encorafenib" (1 trials), "Fulvestrant" (1 trials), "Letrozole" (1 trials) and "PF-07220060" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Health Professionals" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Michigan Health Professionals". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Michigan Health Professionals, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Health Professionals, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".